SCHEMBL6512771

SCHEMBL6512771

COc1ccc(Sc2cc(N[C@@H](CC(C)C)C(=O)NCCN3CCOCC3)nc(Nc3cccc(F)c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 2/20 0.44
CTSK P43235 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TACR2 P21452 3/20 0.39
TSHR P16473 1/20 0.39
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MMP1 P03956 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
SRC P12931 1/20 0.38
SYK P43405 1/20 0.38
GSK3A P49840 1/20 0.38
MAPK14 Q16539 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509302 0.95 PDPK1 (0.41) PDPK1CTSKMEN1KMT2ACYP2C9
SCHEMBL6513421 0.90 PLK4 (0.38) PDPK1CTSKCYP2C19SYKKDM4E
SCHEMBL6531499 0.89 PDPK1 (0.45) PDPK1CTSKMEN1KMT2ACYP2C9
SCHEMBL6509303 0.87 PDPK1 (0.40) PDPK1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL8299305 0.83 CTSK (0.38) CTSKCYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL6507808 0.83 CTSK (0.40) CTSKCYP2C9CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL6528788 0.83 CTSK (0.43) PDPK1CTSKPOLB
SCHEMBL6510135 0.81 CTSK (0.44) CTSK
SCHEMBL6510161 0.81 CTSK (0.44) CTSKSMN1; SMN2
SCHEMBL6506223 0.80 CTSK (0.42) CTSKMEN1KMT2ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed